Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.
作者:
主题词
投药, 口服(Administration, Oral);动物(Animals);细胞, 培养的(Cells, Cultured);共同培养技术(Coculture Techniques);胶原Ⅴ型(Collagen Type V);环孢菌素(Cyclosporine);剂量效应关系, 免疫(Dose-Response Relationship, Immunologic);药物疗法, 联合(Drug Therapy, Combination);移植物排斥(Graft Rejection);组织相容性抗原(Histocompatibility Antigens);组织相容性抗原Ⅱ类(Histocompatibility Antigens Class II);组织相容性试验(Histocompatibility Testing);免疫抑制剂(Immunosuppressive Agents);肺移植(Lung Transplantation);男(雄)性(Male);大鼠(Rats);大鼠, 近交BN(Rats, Inbred BN);大鼠, 近交WKY(Rats, Inbred WKY);移植耐受(Transplantation Tolerance)
DOI
10.4049/jimmunol.0804028
PMID
19542435
发布时间
2021-10-20
- 浏览6
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文